Graft Versus Host Disease Treatment Market: Challenges to Opportunities
Market Overview The Graft Versus Host Disease (GvHD) Treatment Market is poised for significant growth, driven by the increasing prevalence of hematological disorders and advancements in therapeutic strategies. In 2024, the market is valued at USD 2,825 million, with projections estimating a rise to USD 5,306.84 million by 2032, at a CAGR of 8.2%. This…